Drug intelligence / Profile preview

Longvida

Development stage
Phase 1
Lead developer
Verdure Sciences
Modality
Small Molecules, Nanoparticles → Drug Delivery Systems
Administration
Oral
01

Overview

Longvida is a patented formulation of curcumin developed by Verdure Sciences in collaboration with neuroscientists at the University of California, Los Angeles (UCLA). It utilizes Solid Lipid Curcumin Particle (SLCP) technology, which encapsulates curcumin in a lipid matrix to significantly enhance its bioavailability and facilitate its passage across the blood-brain barrier. Curcumin, the primary bioactive component of turmeric (Curcuma longa), is known for its potent anti-inflammatory and antioxidant properties. Longvida is primarily targeted toward supporting cognitive function and joint health. Its mechanism of action involves the inhibition of pro-inflammatory cytokines, reduction of oxidative stress, and the potential prevention of amyloid-beta plaque aggregation, a hallmark of Alzheimer's disease.

Brand names
Longvida
Other names
Solid Lipid Curcumin ParticlesSLCP technology
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)

Beyond the preview

Go deeper on Longvida.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Longvida.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call